Risk of parkinsonism and related movement disorders with gabapentinoids or tramadol: A case-crossover study.

Ri, Kairi; Fukasawa, Toshiki; Yoshida, Satomi; Takeuchi, Masato; Kawakami, Koji

Ri, Kairi; Fukasawa, Toshiki; Yoshida, Satomi; Takeuchi, Masato; Kawakami, Koji.

Afiliación

Ri K; Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
Fukasawa T; Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
Yoshida S; Department of Digital Health and Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
Takeuchi M; Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
Kawakami K; Department of Digital Health and Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.

Pharmacotherapy ; 43(2): 136-144, 2023 02.

Article en En | MEDLINE | ID: mdl-36633384

Asunto(s)

Trastornos Parkinsonianos; Tramadol; Humanos; Tramadol/efectos adversos; Estudios Cruzados; Gabapentina/efectos adversos; Pregabalina/efectos adversos; Trastornos Parkinsonianos/inducido químicamente; Analgésicos Opioides/efectos adversos

Palabras clave

case-crossover studies; drug safety; gabapentin; pharmacoepidemiology; pregabalin; tramadol

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tramadol / Trastornos Parkinsonianos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Pharmacotherapy Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google